PHASE-II STUDY OF AN INTENSIVE COMBINATION CHEMOTHERAPY WITH CISPLATIN, ADRIAMYCIN, ETOPOSIDE AND CYCLOPHOSPHAMIDE (CAVE) IN SMALL CELL LUNG-CANCER

被引:12
|
作者
SCULIER, JP
KLASTERSKY, J
BECQUART, D
VANDERMOTEN, G
VANHOUTTE, P
ROCMANS, P
THIRIAUX, J
LONGEVAL, E
RAVEZ, P
LIBERT, P
FLEMALLE, A
MICHEL, J
MAIRESSE, M
MOMMEN, P
DALESIO, O
机构
来源
关键词
D O I
10.1016/S0277-5379(98)90032-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:519 / 526
页数:8
相关论文
共 50 条
  • [41] CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, AND VINDESINE COMBINATION CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER
    KELSEN, D
    GRALLA, R
    STOOPLER, M
    CASPER, E
    CHENG, E
    KOSLOFF, C
    GOLBEY, R
    CANCER TREATMENT REPORTS, 1982, 66 (02): : 247 - 251
  • [42] A PILOT PHASE-II TRIAL OF A COMBINATION OF CISPLATIN AND CARBOPLATIN IN NONSMALL CELL LUNG-CANCER
    OHNO, S
    KOBAYASHI, J
    SUGIYAMA, Y
    KITAMURA, S
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A749 - A749
  • [43] A PHASE-II STUDY OF IFOSFAMIDE, CISPLATIN, ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A PRELIMINARY-REPORT
    SHEPHERD, FA
    GOSS, PE
    LATREILLE, J
    STEWART, D
    LOGAN, D
    EVANS, WK
    MAROUN, J
    WARNER, E
    SEMINARS IN ONCOLOGY, 1990, 17 (02) : 19 - 23
  • [44] COMBINATION CHEMOTHERAPY WITH VINORELBINE, IFOSFAMIDE, AND CISPLATIN - A PHASE-II STUDY IN STAGE IIIB-IV NONSMALL CELL LUNG-CANCER
    BALDINI, E
    TIBALDI, C
    CHELLA, A
    ANGELETTI, CA
    ROMANINI, A
    ANDREI, A
    ALGERI, R
    SILVANO, G
    CONTE, PF
    SEMINARS IN ONCOLOGY, 1994, 21 (03) : 12 - 15
  • [45] A phase II study of carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer
    Makimoto, T
    Tsuchiya, S
    Nakano, H
    Watanabe, S
    Minato, K
    Takise, A
    Ezawa, K
    Fueki, N
    Naruse, I
    Nomoto, T
    Takei, Y
    Ishihara, S
    Mori, M
    Saitoh, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (01): : 51 - 54
  • [46] AMBULATORY COMBINATION CHEMOTHERAPY WITH ORAL ETOPOSIDE AND CISPLATIN FOR ADVANCED NON-SMALL CELL LUNG-CARCINOMA PATIENTS - A PHASE-II STUDY
    FOCAN, C
    LEHUNG, S
    FRERE, MH
    SCHALLIER, D
    ANTICANCER RESEARCH, 1986, 6 (05) : 977 - 981
  • [47] PILOT-STUDY OF CYCLOPHOSPHAMIDE-DOXORUBICIN-VINCRISTINE-CISPLATIN-ETOPOSIDE HYBRID CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
    OHNOSHI, T
    HIRAKI, S
    UEOKA, H
    KIURA, K
    KAMEI, H
    HORIGUCHI, T
    KODANI, T
    MAEDA, T
    TABATA, M
    SHIBAYAMA, T
    SEGAWA, Y
    MIYATAKE, K
    TAKIGAWA, N
    KIMURA, I
    CANCER, 1993, 72 (05) : 1597 - 1601
  • [48] CARBOPLATIN AND ETOPOSIDE (CARE) COMBINED WITH RADIOTHERAPY AND VINCRISTINE, DOXORUBICIN AND CYCLOPHOSPHAMIDE (VAC) IN LIMITED SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
    VIREN, M
    LIIPPO, K
    OJALA, A
    HELLE, L
    JAKOBSON, M
    JARVINEN, M
    PALOHEIMO, S
    SALOMAA, ER
    SALMI, R
    NIKKANEN, V
    ACTA ONCOLOGICA, 1992, 31 (07) : 761 - 765
  • [49] A PHASE-II TRIAL OF CISPLATIN AND PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
    MURPHY, PB
    HAINSWORTH, JD
    GRECO, FA
    HANDE, KR
    DEVORE, RF
    JOHNSON, DH
    CANCER, 1992, 69 (02) : 370 - 375
  • [50] 5-DAY CONTINUOUS INFUSION OF CISPLATIN AND ETOPOSIDE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II TRIAL
    MARECHAL, F
    BERTHIOT, G
    CATTAN, A
    ACTA ONCOLOGICA, 1990, 29 (08) : 989 - 994